- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/30 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Patent holdings for IPC class C07K 16/30
Total number of patents in this class: 12187
10-year publication summary
|
916
|
961
|
945
|
967
|
887
|
903
|
856
|
910
|
823
|
188
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1120 |
409 |
| Genentech, Inc. | 4052 |
201 |
| Regeneron Pharmaceuticals, Inc. | 4570 |
172 |
| Hoffmann-La Roche Inc. | 3665 |
158 |
| The Regents of the University of California | 20473 |
154 |
| F. Hoffmann-La Roche AG | 7832 |
142 |
| Memorial Sloan-Kettering Cancer Center | 1993 |
137 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2956 |
132 |
| Amgen Inc. | 4327 |
131 |
| The Trustees of the University of Pennsylvania | 4392 |
125 |
| Chugai Seiyaku Kabushiki Kaisha | 1390 |
117 |
| Janssen Biotech, Inc. | 1653 |
113 |
| Amgen Research (Munich) GmbH | 260 |
99 |
| Novartis AG | 10376 |
94 |
| The Board of Trustees of the Leland Stanford Junior University | 6593 |
90 |
| Board of Regents, The University of Texas System | 6018 |
89 |
| SeaGen Inc | 549 |
87 |
| Immunomedics, Inc. | 248 |
86 |
| Daiichi Sankyo Company, Limited | 1881 |
83 |
| Dana-Farber Cancer Institute, Inc. | 2622 |
83 |
| Other owners | 9485 |